[Myeloproliferative disorder and hepatocellular adenoma following androgen treatment of a patient with aplastic anemia (author's transl)]
- PMID: 216824
[Myeloproliferative disorder and hepatocellular adenoma following androgen treatment of a patient with aplastic anemia (author's transl)]
Similar articles
-
Multiple tumors after androgen therapy.Arch Pathol Lab Med. 1977 Nov;101(11):600-3. Arch Pathol Lab Med. 1977. PMID: 199136
-
Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.Am J Hematol. 2004 Nov;77(3):257-67. doi: 10.1002/ajh.20183. Am J Hematol. 2004. PMID: 15495253 Review.
-
[Androgenic therapy and hepatocellular carcinoma. Report of a case].Rev Gastroenterol Mex. 1979 Jan-Apr;44(1):35-40. Rev Gastroenterol Mex. 1979. PMID: 223217 Spanish.
-
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.Lancet. 1972 Dec 16;2(7790):1273-6. doi: 10.1016/s0140-6736(72)92649-9. Lancet. 1972. PMID: 4117807 No abstract available.
-
Hepatoma associated with androgen therapy for aplastic anemia.J Pediatr. 1974 Jan;84(1):109-10. doi: 10.1016/s0022-3476(74)80565-2. J Pediatr. 1974. PMID: 12119927 Review. No abstract available.